Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-11-18

Clinical Trial Update: Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the feasibility of haploidentical hematopoietic stem cell transplantation using CAMPATH-1H in acute myeloid leukemia and acute lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Campath-1H (alemtuzumab)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute | Phase 1 | Status: COMPLETED